HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: fj.06-6505comv1 21/8/1647    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Partlow, K. C. Articles by Wickline, S. A. Search for Related Content PubMed PubMed Citation Articles by Partlow, K. C. Articles by Wickline, S. A.

¹⁹F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons

Kathryn C. Partlow^*, Junjie Chen^*, Jason A. Brant^*, Anne M. Neubauer^*, Todd E. Meyerrose^*, Michael H. Creer, Jan A. Nolta^*, Shelton D. Caruthers^*,, Gregory M. Lanza^* and Samuel A. Wickline^*,1

^* Department of Medicine, Washington University in St. Louis, School of Medicine, St. Louis, Missouri, USA;

Departments of Pathology and Laboratory Medicine, Saint Louis University School of Medicine, St. Louis, Missouri, USA; and

Philips Medical Systems, Andover, Massachusetts, USA

¹Correspondence: Washington University School of Medicine, Campus Box 8215, 660 South Euclid Ave., St. Louis, MO, USA 63110. E-mail: saw{at}howdy.wustl.edu

MRI has been employed to elucidate the migratory behavior of stem/progenitor cells noninvasively in vivo with traditional proton (¹H) imaging of iron oxide nanoparticle-labeled cells. Alternatively, we demonstrate that fluorine (¹⁹F) MRI of cells labeled with different types of liquid perfluorocarbon (PFC) nanoparticles produces unique and sensitive cell markers distinct from any tissue background signal. To define the utility for cell tracking, mononuclear cells harvested from human umbilical cord blood were grown under proendothelial conditions and labeled with nanoparticles composed of two distinct PFC cores (perfluorooctylbromide and perfluoro-15-crown-5 ether). The sensitivity for detecting and imaging labeled cells was defined on 11.7T (research) and 1.5T (clinical) scanners. Stem/progenitor cells (CD34⁺CD133⁺CD31⁺) readily internalized PFC nanoparticles without aid of adjunctive labeling techniques, and cells remained functional in vivo. PFC-labeled cells exhibited distinct ¹⁹F signals and were readily detected after both local and intravenous injection. PFC nanoparticles provide an unequivocal and unique signature for stem/progenitor cells, enable spatial cell localization with ¹⁹F MRI, and permit quantification and detection of multiple fluorine signatures via ¹⁹F MR spectroscopy. This method should facilitate longitudinal investigation of cellular events in vivo for multiple cell types simultaneously.—Partlow, K. C., Chen, J., Brant, J. A., Neubauer, A. M., Meyerrose, T. E., Creer, M. H., Nolta, J. A., Caruthers, S. D., Lanza, G. M., Wickline, S. A. ¹⁹F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons.

Key Words: endothelial progenitor cells • nanoparticles • contrast agent

This article has been cited by other articles:

				B. Ebner, P. Behm, C. Jacoby, S. Burghoff, B. A. French, J. Schrader, and U. Flogel Early Assessment of Pulmonary Inflammation by 19F MRI In Vivo Circ Cardiovasc Imaging, March 1, 2010; 3(2): 202 - 210. [Abstract] [Full Text] [PDF]

				J. V. Terrovitis, R. R. Smith, and E. Marban Assessment and Optimization of Cell Engraftment After Transplantation Into the Heart Circ. Res., February 19, 2010; 106(3): 479 - 494. [Abstract] [Full Text] [PDF]

				M. A. Kuliszewski, H. Fujii, C. Liao, A. H. Smith, A. Xie, J. R. Lindner, and H. Leong-Poi Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles Cardiovasc Res, September 1, 2009; 83(4): 653 - 662. [Abstract] [Full Text] [PDF]

				D. L. Kraitchman and J. W.M. Bulte In Vivo Imaging of Stem Cells and Beta Cells Using Direct Cell Labeling and Reporter Gene Methods Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1025 - 1030. [Abstract] [Full Text] [PDF]

				M. Oostendorp, M. J. Post, and W. H. Backes Vessel Growth and Function: Depiction with Contrast-enhanced MR Imaging Radiology, May 1, 2009; 251(2): 317 - 335. [Abstract] [Full Text] [PDF]

				M. D. Budde and J. A. Frank Magnetic Tagging of Therapeutic Cells for MRI J. Nucl. Med., February 1, 2009; 50(2): 171 - 174. [Abstract] [Full Text] [PDF]

				M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al. Multimodality Cardiovascular Molecular Imaging, Part II Circ Cardiovasc Imaging, January 1, 2009; 2(1): 56 - 70. [Full Text] [PDF]

				Z. Lee, J. E. Dennis, and S. L. Gerson Imaging Stem Cell Implant for Cellular-Based Therapies Exp Biol Med, August 1, 2008; 233(8): 930 - 940. [Abstract] [Full Text] [PDF]

				U. Flogel, Z. Ding, H. Hardung, S. Jander, G. Reichmann, C. Jacoby, R. Schubert, and J. Schrader In Vivo Monitoring of Inflammation After Cardiac and Cerebral Ischemia by Fluorine Magnetic Resonance Imaging Circulation, July 8, 2008; 118(2): 140 - 148. [Abstract] [Full Text] [PDF]

				K. K. Jain Applications of Nanobiotechnology in Clinical Diagnostics Clin. Chem., November 1, 2007; 53(11): 2002 - 2009. [Abstract] [Full Text] [PDF]